CoChat

LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro

Open access
Cherepanov, Peter · 2007 · Nucleic Acids Research

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Abstract

Transcriptional co-activator LEDGF/p75 is the major cellular interactor of HIV-1 integrase (IN), critical to efficient viral replication. In this work, a series of INs from the Betaretrovirus, Gammaretrovirus, Deltaretrovirus, Spumavirus and Lentivirus retroviral genera were tested for interaction with the host factor. None of the non-lentiviral INs possessed detectable affinity for LEDGF in either pull-down or yeast two-hybrid assays. In contrast, all lentiviral INs examined, including those from bovine immunodeficiency virus (BIV), maedi-visna virus (MVV) and equine infectious anemia virus (EIAV) readily interacted with LEDGF. Mutation of Asp-366 to Asn in LEDGF ablated the interaction, suggesting a common mechanism of the host factor recognition by the INs. LEDGF potently stimulated strand transfer activity of divergent lentiviral INs in vitro. Unprecedentedly, in the presence of the host factor, EIAV IN almost exclusively catalyzed concerted integration, whereas HIV-1 IN promoted predominantly half-site integration, and BIV IN was equally active in both types of strand transfer. Concerted BIV and EIAV integration resulted in 5 bp duplications of the target DNA sequences. These results confirm that the interaction with LEDGF is conserved within and limited to Lentivirus and strongly argue that the host factor is intimately involved in the catalysis of lentiviral DNA integration.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/nar/gkl885

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Interaction with LEDGF is limited to and conserved among lentiviral INs. (A) His6-tagged HIV-1, HIV-2, PFV, MPMV, FeLV and HTLV-1 INs (as indicated) were tested for the ability to pull-down WT (lanes 2–8) or D366N LEDGF (lanes 10 and 11). Proteins recovered on Ni-NTA agarose beads were separated in SDS–PAGE gels and detected by staining with Coomassie-R250. Lanes 1 and 9 contained input quantities of WT and D366N LEDGF, respectively. The migration positions of LEDGF and molecular weight markers (kDa) are indicated. (B) His6-tag pull-down assays with lentiviral HIV-1, EIAV, MVV and BIV INs (as indicated) and WT (lanes 3–7) or D366N LEDGF (lanes 10–14). Lanes 1 and 8 contained input quantities of WT and D366N LEDGF. IN was omitted from reactions in lanes 2 and 9.
Figure 1 Interaction with LEDGF is limited to and conserved among lentiviral INs. (A) His6-tagged HIV-1, HIV-2, PFV, MPMV, FeLV and HTLV-1 INs (as indicated) were tested for the ability to pull-down WT (lanes 2–8) or D366N LEDGF (lanes 10 and 11). Proteins recovered on Ni-NTA agarose beads were separated in SDS–PAGE gels and detected by staining with Coomassie-R250. Lanes 1 and 9 contained input quantities of WT and D366N LEDGF, respectively. The migration positions of LEDGF and molecular weight markers (kDa) are indicated. (B) His6-tag pull-down assays with lentiviral HIV-1, EIAV, MVV and BIV INs (as indicated) and WT (lanes 3–7) or D366N LEDGF (lanes 10–14). Lanes 1 and 8 contained input quantities of WT and D366N LEDGF. IN was omitted from reactions in lanes 2 and 9.CC BY-NC · PubMed Central
Figure 2 LEDGF stimulates gross strand transfer activity of HIV-1, BIV and EIAV INs. Reactions containing mini-HIV (lanes 1–5), mini-BIV (lanes 6–10) or mini-EIAV (lanes 11–15) DNAs were incubated in the presence of 0.6 μM (∼20 μg/ml) non-tagged recombinant HIV-1 (lanes 2–5), BIV (lanes 7–10) or EIAV (lanes 12–15) IN. LEDGF was added to the reactions in lanes 3–5, 8–10 and 13–15 at indicated concentrations. The proteins were omitted from the mock reactions in lanes 1, 6 and 11.
Figure 2 LEDGF stimulates gross strand transfer activity of HIV-1, BIV and EIAV INs. Reactions containing mini-HIV (lanes 1–5), mini-BIV (lanes 6–10) or mini-EIAV (lanes 11–15) DNAs were incubated in the presence of 0.6 μM (∼20 μg/ml) non-tagged recombinant HIV-1 (lanes 2–5), BIV (lanes 7–10) or EIAV (lanes 12–15) IN. LEDGF was added to the reactions in lanes 3–5, 8–10 and 13–15 at indicated concentrations. The proteins were omitted from the mock reactions in lanes 1, 6 and 11.CC BY-NC · PubMed Central
Figure 3 Strand transfer activities of HIV-1, BIV and EIAV INs in the presence of LEDGF. (A) Schematic of in vitro integration with circular DNA target and the expected linear concerted and circular half site strand transfer products. Coordinated insertion of a pair of substrate DNA molecules into opposing strands of target DNA results in a linear concerted integration product (left). Uncoupled insertion of a single substrate molecule into one strand of the target plasmid gives a circular half site product (right). Thick lines are substrate and thin are target-derived DNA. (B) HIV-1 (lanes 1–6), BIV (lanes 7–11), or EIAV (lanes 12–16) RU5 substrates and supercoiled pGEM target DNA were incubated with 0.6 μM (∼20 μg/ml) recombinant HIV-1, BIV, or EIAV INs and 0–0.4 μM LEDGF, as indicated. Deproteinized reaction products were separated in 1.5% agarose gels and detected by staining with ethidium bromide. Lanes 17 and 18 contained nicked circular and linearized pGEM DNA respectively. Migration positions of DNA markers (kb), pGEM DNA forms [supercoiled multimer (s.c. mult.), nicked circular, linear, and supercoiled (s.c.)], substrate RU5 DNAs, and the reaction products (concerted, half-site, and multiple half-site) are indicated. (C) BIV (lanes 1–6) and EIAV (lanes 7–12) integration reactions were carried out with the respective RU5 or/and RU5+300 substrates. Lanes 13 and 14 contained nicked circular and linearized pGEM DNA, respectively. Migration positions of the two circular half site and three linear concerted integration products derived from RU5 and RU5+300 substrates are indicated.
Figure 3 Strand transfer activities of HIV-1, BIV and EIAV INs in the presence of LEDGF. (A) Schematic of in vitro integration with circular DNA target and the expected linear concerted and circular half site strand transfer products. Coordinated insertion of a pair of substrate DNA molecules into opposing strands of target DNA results in a linear concerted integration product (left). Uncoupled insertion of a single substrate molecule into one strand of the target plasmid gives a circular half site product (right). Thick lines are substrate and thin are target-derived DNA. (B) HIV-1 (lanes 1–6), BIV (lanes 7–11), or EIAV (lanes 12–16) RU5 substrates and supercoiled pGEM target DNA were incubated with 0.6 μM (∼20 μg/ml) recombinant HIV-1, BIV, or EIAV INs and 0–0.4 μM LEDGF, as indicated. Deproteinized reaction products were separated in 1.5% agarose gels and detected by staining with ethidium bromide. Lanes 17 and 18 contained nicked circular and linearized pGEM DNA respectively. Migration positions of DNA markers (kb), pGEM DNA forms [supercoiled multimer (s.c. mult.), nicked circular, linear, and supercoiled (s.c.)], substrate RU5 DNAs, and the reaction products (concerted, half-site, and multiple half-site) are indicated. (C) BIV (lanes 1–6) and EIAV (lanes 7–12) integration reactions were carried out with the respective RU5 or/and RU5+300 substrates. Lanes 13 and 14 contained nicked circular and linearized pGEM DNA, respectively. Migration positions of the two circular half site and three linear concerted integration products derived from RU5 and RU5+300 substrates are indicated.CC BY-NC · PubMed Central
Figure 4 Time course of LEDGF-dependent HIV-1, BIV and EIAV integration reactions with radiolabeled donor DNA substrates. HIV-1 (lanes 1–9), BIV (lanes 10–18) and EIAV (lanes 19–27) RU5 substrates were incubated with their respective INs (0.6 μM) for 5–90 min (as indicated), in the presence (lanes 2–6, 11–15 and 20–24) or absence (lanes 7–9, 16–18 and 25–27) of 0.4 μM LEDGF. Deproteinized reaction products separated in 1.5% agarose gels were detected and quantified by phosphor autoradiography. Lanes 1, 10 and 19 contained mock samples where IN and LEDGF were omitted. Migration positions of DNA standards (kb) are indicated. The plot below each gel shows accumulation of the concerted (filled circles) or half-site (triangles) integration products in the presence (discontinuous line) or absence (dashed line) of LEDGF in terms of relative band intensity. Error bars represent SDs calculated from duplicate measurements.
Figure 4 Time course of LEDGF-dependent HIV-1, BIV and EIAV integration reactions with radiolabeled donor DNA substrates. HIV-1 (lanes 1–9), BIV (lanes 10–18) and EIAV (lanes 19–27) RU5 substrates were incubated with their respective INs (0.6 μM) for 5–90 min (as indicated), in the presence (lanes 2–6, 11–15 and 20–24) or absence (lanes 7–9, 16–18 and 25–27) of 0.4 μM LEDGF. Deproteinized reaction products separated in 1.5% agarose gels were detected and quantified by phosphor autoradiography. Lanes 1, 10 and 19 contained mock samples where IN and LEDGF were omitted. Migration positions of DNA standards (kb) are indicated. The plot below each gel shows accumulation of the concerted (filled circles) or half-site (triangles) integration products in the presence (discontinuous line) or absence (dashed line) of LEDGF in terms of relative band intensity. Error bars represent SDs calculated from duplicate measurements.CC BY-NC · PubMed Central
Figure 5 Sequence analysis of cloned EIAV and BIV integration products. (A) Pie charts summarizing the categories of clones obtained by cloning of the gel-purified concerted linear integration products. In total, 30 EIAV- and 26 BIV- derived clones were analyzed. See the Results section for more details. (B) Distribution of the cloned concerted integration events along the pGEM target. The histogram bars represent numbers of EIAV (black) and BIV (gray) integration events within each 25 bp window along the target DNA sequence. The ruler corresponds to nucleotide coordinates within pGEM-9Zf(−) (GenBank accession no. X65312). Positions of the plasmid's replication origin (ori) and the ampicillin resistance gene (bla) are indicated.
Figure 5 Sequence analysis of cloned EIAV and BIV integration products. (A) Pie charts summarizing the categories of clones obtained by cloning of the gel-purified concerted linear integration products. In total, 30 EIAV- and 26 BIV- derived clones were analyzed. See the Results section for more details. (B) Distribution of the cloned concerted integration events along the pGEM target. The histogram bars represent numbers of EIAV (black) and BIV (gray) integration events within each 25 bp window along the target DNA sequence. The ruler corresponds to nucleotide coordinates within pGEM-9Zf(−) (GenBank accession no. X65312). Positions of the plasmid's replication origin (ori) and the ampicillin resistance gene (bla) are indicated.CC BY-NC · PubMed Central
Figure 6 Partial sequence alignment of lentiviral INs. Secondary structure elements from 2B4J (32) are indicated above the alignment. Residues comprising the α4/5 connector (167–171 in HIV-1 IN) (32) are boxed. Residues invariant among all six proteins are white on red background, and those with conserved biochemical properties are bold on yellow background. Blue circles and boxes under the alignment indicate residues that in HIV-1 CCD-IBD structure directly participate in the interaction with LEDGF through side chain or backbone atoms, respectively (32). The numbering corresponds to the HIV-1 sequence. The figure was generated using ESPript-2.2 (64), ().
Figure 6 Partial sequence alignment of lentiviral INs. Secondary structure elements from 2B4J (32) are indicated above the alignment. Residues comprising the α4/5 connector (167–171 in HIV-1 IN) (32) are boxed. Residues invariant among all six proteins are white on red background, and those with conserved biochemical properties are bold on yellow background. Blue circles and boxes under the alignment indicate residues that in HIV-1 CCD-IBD structure directly participate in the interaction with LEDGF through side chain or backbone atoms, respectively (32). The numbering corresponds to the HIV-1 sequence. The figure was generated using ESPript-2.2 (64), ().CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 186

Metadata

Authors
Cherepanov, P.
Affiliations
Imperial College London (GB)
Corresponding author
Cherepanov, Peter
Venue
Nucleic Acids Research
Published
2006-12-07
Volume
35
Issue
1
Pages
113-124
ISSN
  • 0305-1048 (ISSN-L)
  • 1362-4962
OpenAlex
W2136975219
Cited by
173
References
64
Citations by year
2026: 5 · 2025: 6 · 2024: 1 · 2023: 2 · 2022: 10 · 2021: 8 · 2020: 7 · 2019: 7 · 2018: 10 · 2017: 8 · 2016: 6 · 2015: 15 · 2014: 6 · 2013: 8 · 2012: 10
FWCI
4.51
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Nucleic Acids Research (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Spiral (Imperial College London) (submittedVersion, cc-by-nc)
Funders
  • Imperial College London
  • University College London
  • Háskóli Íslands
  • National Institutes of Health
  • Medical Research Council
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
Keywords
LEDGF/p75, HIV-1 integrase, strand transfer, bovine immunodeficiency virus, maedi-visna virus, equine infectious anemia virus, DNA integration, retroviral replication
MeSH terms
Animals, Cattle, DNA, Viral, Enzyme Activation, Infectious Anemia Virus, Equine, Horses, Humans, Retroviridae, Transcription Factors, Viral Proteins, Lentivirus, Immunodeficiency Virus, Bovine, Sequence Analysis, DNA, Integrases, Intercellular Signaling Peptides and Proteins, Adaptor Proteins, Signal Transducing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.